• SALIX PHARMACEUTICALS INC Financial Overview

  • Income Statement: SLXP

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 235.79 M 208.53 M 27.26 M 11.56%
    Gross Profit 170.32 M 160.89 M 9.43 M 5.54%
    Net Income Before Extra Items/Preferred Div 8.22 M 31.51 M -23.28 M -283.10%
    Operating Income 11.85 M 30.33 M -18.48 M -155.94%
  • Cash Flow: SLXP

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing 18.08 M 4.21 M 13.86 M 76.69%
    Net Cash Flow - Investing 59.42 M 12.83 M 46.60 M 78.42%
    Net Cash Flow/Operating Activities 76.15 M 17.89 M 58.26 M 76.50%
  • Balance Sheet: SLXP

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 397.10 M 323.12 M 73.98 M 18.63%
    Total Liabilities 104.53 M 45.57 M 58.96 M 56.40%
    Shareholders Equity 292.57 M 277.55 M 15.02 M 5.13%
  • Key Ratios / Statistics: SLXP

    • Valuation

      Price/Earnings (TTM) 46.35
      Price/Sales (TTM) 1.63
      Price/Book (MRQ) 1.27
      Price/Cash Flow (TTM) -16.96
    • Profitability

      Gross Margin 72.23
      Operating Margin 5.03
      Profit Margin 3.49
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.89
      Current Ratio (MRQ) 2.22
      Long Term Debt-to-Equity (MRQ) 5.69
    • Management Effectiveness

      Return on Equity (TTM) 2.87
      Return on Assets (TTM) 2.28
      Return on Investments (TTM) 2.80